GlaxoSmithkline
Stock
Stock
ISIN: GB00BN7SWP63
Ticker: GSK
GB00BN7SWP63
GSK
Price
Price
CHART BY
Historical dividends and forecast
GlaxoSmithkline has so far distributed $0.685 in 2026. The next dividend will be paid on 08.10.2026
$1.369
CHART BY
Frequently asked questions
What is GlaxoSmithkline's market capitalization?
The market capitalization of GlaxoSmithkline is $94.20B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is GlaxoSmithkline's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for GlaxoSmithkline is 14.86. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for GlaxoSmithkline?
GlaxoSmithkline's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.582. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for GlaxoSmithkline's stock?
Currently, 23 analysts cover GlaxoSmithkline's stock, with a consensus target price of $28.48. Analyst ratings provide insights into the stock's expected performance.
What is GlaxoSmithkline's revenue over the trailing twelve months?
Over the trailing twelve months, GlaxoSmithkline reported a revenue of $43.86B.
Is GlaxoSmithkline paying dividends?
Yes, GlaxoSmithkline is paying dividends. The next payment is scheduled for 08.10.2026, with an expected amount of .
What is the EBITDA for GlaxoSmithkline?
GlaxoSmithkline's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $13.88B. EBITDA measures the company's overall financial performance.
What is the free cash flow of GlaxoSmithkline?
GlaxoSmithkline has a free cash flow of $8.57B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does GlaxoSmithkline have, and what sector and industry does it belong to?
GlaxoSmithkline employs approximately 66,841 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of GlaxoSmithkline's shares?
The free float of GlaxoSmithkline is 3.88B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $94.20B
- EPS (TTM)
- $1.582
- Free Float
- 3.88B
- P/E ratio (TTM)
- 14.86
- Revenue (TTM)
- $43.86B
- EBITDA (TTM)
- $13.88B
- Free Cashflow (TTM)
- $8.57B
Pricing
- 1D span
- $23.34$23.81
- 52W span
- $21.18$30.80
Analyst Ratings
The price target is $28.48 and the stock is covered by 23 analysts.
Buy
7
Hold
12
Sell
4
Information
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.
- Employees
- 66,841
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- GB00BN7SWP63
- Primary Ticker
- GSK
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet